Report Detail
Global G-CSF Biosimilars Market Research Report 2019
- RnM3184967 |
- 25 March, 2019 |
- Global |
- 103 Pages |
- QYResearch |
- Pharma & Healthcare
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor
Company profiles are primarily based on public domain information including company
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Pfizer
Novartis
Roche
The global G-CSF Biosimilars market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on G-CSF Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall G-CSF Biosimilars market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Segment by Application
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
Table of Contents
Executive Summary
1 G-CSF Biosimilars Market Overview
- 1.1 Product Overview and Scope of G-CSF Biosimilars
- 1.2 G-CSF Biosimilars Segment by Type
- 1.2.1 Global G-CSF Biosimilars Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Human Growth Hormone
- 1.2.3 Erythropoietin
- 1.2.4 Monoclonal Antibodies
- 1.2.5 Insulin
- 1.2.6 Interferon
- 1.2.7 Granulocyte-Colony Stimulating Factor
- 1.3 G-CSF Biosimilars Segment by Application
- 1.3.1 G-CSF Biosimilars Consumption Comparison by Application (2014-2025)
- 1.3.2 Blood Disorders
- 1.3.3 Oncology Diseases
- 1.3.4 Chronic And Autoimmune Diseases
- 1.3.5 Growth Hormone Deficiencies
- 1.4 Global G-CSF Biosimilars Market by Region
- 1.4.1 Global G-CSF Biosimilars Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global G-CSF Biosimilars Market Size
- 1.5.1 Global G-CSF Biosimilars Revenue (2014-2025)
- 1.5.2 Global G-CSF Biosimilars Production (2014-2025)
2 Global G-CSF Biosimilars Market Competition by Manufacturers
- 2.1 Global G-CSF Biosimilars Production Market Share by Manufacturers (2014-2019)
- 2.2 Global G-CSF Biosimilars Revenue Share by Manufacturers (2014-2019)
- 2.3 Global G-CSF Biosimilars Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers G-CSF Biosimilars Production Sites, Area Served, Product Types
- 2.5 G-CSF Biosimilars Market Competitive Situation and Trends
- 2.5.1 G-CSF Biosimilars Market Concentration Rate
- 2.5.2 G-CSF Biosimilars Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global G-CSF Biosimilars Production Market Share by Regions
- 3.1 Global G-CSF Biosimilars Production Market Share by Regions
- 3.2 Global G-CSF Biosimilars Revenue Market Share by Regions (2014-2019)
- 3.3 Global G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America G-CSF Biosimilars Production
- 3.4.1 North America G-CSF Biosimilars Production Growth Rate (2014-2019)
- 3.4.2 North America G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe G-CSF Biosimilars Production
- 3.5.1 Europe G-CSF Biosimilars Production Growth Rate (2014-2019)
- 3.5.2 Europe G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China G-CSF Biosimilars Production (2014-2019)
- 3.6.1 China G-CSF Biosimilars Production Growth Rate (2014-2019)
- 3.6.2 China G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan G-CSF Biosimilars Production (2014-2019)
- 3.7.1 Japan G-CSF Biosimilars Production Growth Rate (2014-2019)
- 3.7.2 Japan G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
4 Global G-CSF Biosimilars Consumption by Regions
- 4.1 Global G-CSF Biosimilars Consumption by Regions
- 4.2 North America G-CSF Biosimilars Consumption (2014-2019)
- 4.3 Europe G-CSF Biosimilars Consumption (2014-2019)
- 4.4 China G-CSF Biosimilars Consumption (2014-2019)
- 4.5 Japan G-CSF Biosimilars Consumption (2014-2019)
5 Global G-CSF Biosimilars Production, Revenue, Price Trend by Type
- 5.1 Global G-CSF Biosimilars Production Market Share by Type (2014-2019)
- 5.2 Global G-CSF Biosimilars Revenue Market Share by Type (2014-2019)
- 5.3 Global G-CSF Biosimilars Price by Type (2014-2019)
- 5.4 Global G-CSF Biosimilars Production Growth by Type (2014-2019)
6 Global G-CSF Biosimilars Market Analysis by Applications
- 6.1 Global G-CSF Biosimilars Consumption Market Share by Application (2014-2019)
- 6.2 Global G-CSF Biosimilars Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in G-CSF Biosimilars Business
- 7.1 Pfizer
- 7.1.1 Pfizer G-CSF Biosimilars Production Sites and Area Served
- 7.1.2 G-CSF Biosimilars Product Introduction, Application and Specification
- 7.1.3 Pfizer G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Novartis
- 7.2.1 Novartis G-CSF Biosimilars Production Sites and Area Served
- 7.2.2 G-CSF Biosimilars Product Introduction, Application and Specification
- 7.2.3 Novartis G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Roche
- 7.3.1 Roche G-CSF Biosimilars Production Sites and Area Served
- 7.3.2 G-CSF Biosimilars Product Introduction, Application and Specification
- 7.3.3 Roche G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Merck & Co.
- 7.4.1 Merck & Co. G-CSF Biosimilars Production Sites and Area Served
- 7.4.2 G-CSF Biosimilars Product Introduction, Application and Specification
- 7.4.3 Merck & Co. G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Sanofi
- 7.5.1 Sanofi G-CSF Biosimilars Production Sites and Area Served
- 7.5.2 G-CSF Biosimilars Product Introduction, Application and Specification
- 7.5.3 Sanofi G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Johnson & Johnson
- 7.6.1 Johnson & Johnson G-CSF Biosimilars Production Sites and Area Served
- 7.6.2 G-CSF Biosimilars Product Introduction, Application and Specification
- 7.6.3 Johnson & Johnson G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Gilead Science
- 7.7.1 Gilead Science G-CSF Biosimilars Production Sites and Area Served
- 7.7.2 G-CSF Biosimilars Product Introduction, Application and Specification
- 7.7.3 Gilead Science G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 GlaxoSmithKline
- 7.8.1 GlaxoSmithKline G-CSF Biosimilars Production Sites and Area Served
- 7.8.2 G-CSF Biosimilars Product Introduction, Application and Specification
- 7.8.3 GlaxoSmithKline G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 AbbVie
- 7.9.1 AbbVie G-CSF Biosimilars Production Sites and Area Served
- 7.9.2 G-CSF Biosimilars Product Introduction, Application and Specification
- 7.9.3 AbbVie G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Amgen
- 7.10.1 Amgen G-CSF Biosimilars Production Sites and Area Served
- 7.10.2 G-CSF Biosimilars Product Introduction, Application and Specification
- 7.10.3 Amgen G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 AstraZeneca
- 7.12 Bayer
8 G-CSF Biosimilars Manufacturing Cost Analysis
- 8.1 G-CSF Biosimilars Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of G-CSF Biosimilars
- 8.4 G-CSF Biosimilars Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 G-CSF Biosimilars Distributors List
- 9.3 G-CSF Biosimilars Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global G-CSF Biosimilars Market Forecast
- 11.1 Global G-CSF Biosimilars Production, Revenue Forecast
- 11.1.1 Global G-CSF Biosimilars Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global G-CSF Biosimilars Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global G-CSF Biosimilars Price and Trend Forecast (2019-2025)
- 11.2 Global G-CSF Biosimilars Production Forecast by Regions (2019-2025)
- 11.2.1 North America G-CSF Biosimilars Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe G-CSF Biosimilars Production, Revenue Forecast (2019-2025)
- 11.2.3 China G-CSF Biosimilars Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan G-CSF Biosimilars Production, Revenue Forecast (2019-2025)
- 11.3 Global G-CSF Biosimilars Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America G-CSF Biosimilars Consumption Forecast (2019-2025)
- 11.3.2 Europe G-CSF Biosimilars Consumption Forecast (2019-2025)
- 11.3.3 China G-CSF Biosimilars Consumption Forecast (2019-2025)
- 11.3.4 Japan G-CSF Biosimilars Consumption Forecast (2019-2025)
- 11.4 Global G-CSF Biosimilars Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global G-CSF Biosimilars Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on G-CSF Biosimilars . Industry analysis & Market Report on G-CSF Biosimilars is a syndicated market report, published as Global G-CSF Biosimilars Market Research Report 2019. It is complete Research Study and Industry Analysis of G-CSF Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
